Market Cap 142.94B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 8.24
Forward PE 8.44
Profit Margin 12.42%
Debt to Equity Ratio 0.71
Volume 82,009,211
Avg Vol 37,858,195
Day's Range N/A - N/A
Shares Out 5.70B
Stochastic %K 2%
Beta 0.34
Analysts Sell
Price Target $29.28

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
nlrmandate
nlrmandate Jun. 24 at 5:00 PM
Hey $PFE management: wanna fix all your SP issues and compete with $LLY ? Simple answer: BUY $VKTX
0 · Reply
MarketPlays_App
MarketPlays_App Jun. 24 at 4:59 PM
a high dividend yield on $PFE is not always what it looks like. yield is the payout divided by the price, so when a stock falls the yield rises even if the dividend never grew. a big yield can just mean the price dropped. worth checking which one it is
0 · Reply
simonds
simonds Jun. 24 at 4:58 PM
$PFE Come on pick up the speed cutting stock price; should be below $23 by now.
0 · Reply
egidio
egidio Jun. 24 at 4:56 PM
$PFE needs to buy vktx
0 · Reply
ians
ians Jun. 24 at 4:52 PM
$IBRX Hey $PFE THINK you may have bet on the wrong asset for 2L NSCLC. 🤷‍♂️ Check out Anktiva if you want to salvage Sigvotatug vedotin. Maybe you can do a combo regimen? 🤔 Dr. PSS was right all along. Solid tumor treatments need to both release the brakes on T-cells & TRIGGER the adaptive immune response while at the same time stimulate the the NK cells's innate immune response. 👍 $20-30 LT PT ☘️💎 "Pfizer said Monday that the therapy, an antibody-drug conjugate called sigvotatug vedotin, didn't significantly extend survival compared to a common chemotherapy in a Phase 3 study in people with advanced, non-squamous non-small cell lung cancer. ... Sigvotatug vedotin's study failure is "unlikely to help confidence" in the Seagen deal and could result in another impairment charge, he added. " https://finance.yahoo.com/healthcare/articles/pfizer-drug-acquired-seagen-deal-120600236.html
0 · Reply
biolover
biolover Jun. 24 at 4:49 PM
0 · Reply
BearBoB
BearBoB Jun. 24 at 4:47 PM
$PFE are we bottomed yet??
1 · Reply
Itsokman
Itsokman Jun. 24 at 4:44 PM
$PFE Market trying to force Bourla out. New CEO will cut dividend, which is good.
2 · Reply
standupwall
standupwall Jun. 24 at 4:41 PM
$PFE Nobody gets meaningful rich holding this stock. Its is just a dividend play, that is why I hold some % of my portfolio in this name, just for the income. To get rich in pharma I am betting in Fulgent Genetics.
0 · Reply
TrustButVerifi
TrustButVerifi Jun. 24 at 4:41 PM
$PFE Bourla is the most imcompetent Fkn Ceo of the century ! All shareholders need to bombard investor relation and ask for his resignation now! $VKTX $LLY $NVO
0 · Reply
Latest News on PFE
Pfizer dismissed from US states' drug price-fixing lawsuit

Jun 24, 2026, 10:51 AM EDT - 2 hours ago

Pfizer dismissed from US states' drug price-fixing lawsuit


Pfizer (PFE) Shares Sink After Surprise CFO Exit

2026-06-18T18:35:11.000Z - 5 days ago

Pfizer (PFE) Shares Sink After Surprise CFO Exit


Pfizer reaffirms all components of FY26 guidance

2026-06-18T17:30:31.000Z - 5 days ago

Pfizer reaffirms all components of FY26 guidance


Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:52 AM EDT - 6 days ago

Pfizer CFO Dave Denton to step down, leave company in August


Pfizer Announces Chief Financial Officer Transition

Jun 18, 2026, 6:45 AM EDT - 6 days ago

Pfizer Announces Chief Financial Officer Transition


Pfizer says FDA approves expanded indication for Hympavzi

2026-06-08T10:51:57.000Z - 16 days ago

Pfizer says FDA approves expanded indication for Hympavzi


US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:49 AM EDT - 16 days ago

US FDA approves Pfizer's bleeding disorder drug for children


Pfizer presents results from Phase 2b studies of berobenatide

2026-06-07T22:00:49.000Z - 16 days ago

Pfizer presents results from Phase 2b studies of berobenatide


Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 18 days ago

Pfizer Transcript: Study update


Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 18 days ago

Pfizer Slides: Study update


Mailbag: A Follow-Up on Pfizer & Other Questions

May 30, 2026, 9:22 AM EDT - 25 days ago

Mailbag: A Follow-Up on Pfizer & Other Questions

AGNC LAND NLY PFFA


Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC

May 5, 2026, 4:09 PM EDT - 7 weeks ago

Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC


Pfizer CEO on AI-designed molecule, and race to use new tech

May 5, 2026, 4:02 PM EDT - 7 weeks ago

Pfizer CEO on AI-designed molecule, and race to use new tech


3 Dividend Stocks for May 2026

May 5, 2026, 11:30 AM EDT - 7 weeks ago

3 Dividend Stocks for May 2026

SYY WSO


Pfizer Earnings Call Transcript: Q1 2026

May 5, 2026, 10:00 AM EDT - 7 weeks ago

Pfizer Earnings Call Transcript: Q1 2026


Pfizer Earnings release: Q1 2026

May 5, 2026, 10:00 AM EDT - 7 weeks ago

Pfizer Earnings release: Q1 2026


Pfizer Quarterly report: Q1 2026

May 5, 2026, 10:00 AM EDT - 7 weeks ago

Pfizer Quarterly report: Q1 2026


Pfizer Slides: Q1 2026

May 5, 2026, 10:00 AM EDT - 7 weeks ago

Pfizer Slides: Q1 2026


Pfizer Posts Better-Than-Expected Revenue, Profit

May 5, 2026, 8:35 AM EDT - 7 weeks ago

Pfizer Posts Better-Than-Expected Revenue, Profit


Why selling these 3 dividend stocks could be a mistake

May 5, 2026, 7:05 AM EDT - 7 weeks ago

Why selling these 3 dividend stocks could be a mistake

EPD UPS


US FDA approves Pfizer, Arvinas' breast cancer drug

May 1, 2026, 12:37 PM EDT - 7 weeks ago

US FDA approves Pfizer, Arvinas' breast cancer drug

ARVN


Pfizer's blood cancer drug meets main goal in late-stage trial

Apr 29, 2026, 7:42 AM EDT - 2 months ago

Pfizer's blood cancer drug meets main goal in late-stage trial


nlrmandate
nlrmandate Jun. 24 at 5:00 PM
Hey $PFE management: wanna fix all your SP issues and compete with $LLY ? Simple answer: BUY $VKTX
0 · Reply
MarketPlays_App
MarketPlays_App Jun. 24 at 4:59 PM
a high dividend yield on $PFE is not always what it looks like. yield is the payout divided by the price, so when a stock falls the yield rises even if the dividend never grew. a big yield can just mean the price dropped. worth checking which one it is
0 · Reply
simonds
simonds Jun. 24 at 4:58 PM
$PFE Come on pick up the speed cutting stock price; should be below $23 by now.
0 · Reply
egidio
egidio Jun. 24 at 4:56 PM
$PFE needs to buy vktx
0 · Reply
ians
ians Jun. 24 at 4:52 PM
$IBRX Hey $PFE THINK you may have bet on the wrong asset for 2L NSCLC. 🤷‍♂️ Check out Anktiva if you want to salvage Sigvotatug vedotin. Maybe you can do a combo regimen? 🤔 Dr. PSS was right all along. Solid tumor treatments need to both release the brakes on T-cells & TRIGGER the adaptive immune response while at the same time stimulate the the NK cells's innate immune response. 👍 $20-30 LT PT ☘️💎 "Pfizer said Monday that the therapy, an antibody-drug conjugate called sigvotatug vedotin, didn't significantly extend survival compared to a common chemotherapy in a Phase 3 study in people with advanced, non-squamous non-small cell lung cancer. ... Sigvotatug vedotin's study failure is "unlikely to help confidence" in the Seagen deal and could result in another impairment charge, he added. " https://finance.yahoo.com/healthcare/articles/pfizer-drug-acquired-seagen-deal-120600236.html
0 · Reply
biolover
biolover Jun. 24 at 4:49 PM
0 · Reply
BearBoB
BearBoB Jun. 24 at 4:47 PM
$PFE are we bottomed yet??
1 · Reply
Itsokman
Itsokman Jun. 24 at 4:44 PM
$PFE Market trying to force Bourla out. New CEO will cut dividend, which is good.
2 · Reply
standupwall
standupwall Jun. 24 at 4:41 PM
$PFE Nobody gets meaningful rich holding this stock. Its is just a dividend play, that is why I hold some % of my portfolio in this name, just for the income. To get rich in pharma I am betting in Fulgent Genetics.
0 · Reply
TrustButVerifi
TrustButVerifi Jun. 24 at 4:41 PM
$PFE Bourla is the most imcompetent Fkn Ceo of the century ! All shareholders need to bombard investor relation and ask for his resignation now! $VKTX $LLY $NVO
0 · Reply
Woodmont
Woodmont Jun. 24 at 4:41 PM
$PFE I believe we are going to start seeing a market shift in sentiment towards dividend producing companies given the uncertainty of huge CAPEX spending in technology
1 · Reply
godisrupt
godisrupt Jun. 24 at 4:40 PM
$PFE is that Divvy safe?
1 · Reply
STOCKPICKERTRADER
STOCKPICKERTRADER Jun. 24 at 4:34 PM
$PFE when out of the woodwork come the going to zero and other nonsense it is like Cramer the fool clown saying stay from Oil at 20/bbl or BMY has no pipeline at 39... and other many others. Time to build/start position here imo
0 · Reply
inv1ncible
inv1ncible Jun. 24 at 4:31 PM
$PFE Bourla still here?
0 · Reply
youngtrendsetter
youngtrendsetter Jun. 24 at 4:28 PM
$PFE under 20
1 · Reply
pfh_investing
pfh_investing Jun. 24 at 4:27 PM
$PFE too cheap at $24. Loaded the boat for a bounce.
3 · Reply
ItsCarRamRod
ItsCarRamRod Jun. 24 at 4:26 PM
$PFE think the board will fire Bourla the wealth destroyer when PFE gets back to single digits?
0 · Reply
lalaloopsyies
lalaloopsyies Jun. 24 at 4:26 PM
$PFE it just needs one good pandemic to get running
1 · Reply
AFJuvat
AFJuvat Jun. 24 at 4:24 PM
$PFE Daily reminder: Everybody don't forget to say BOURLAAAA !
0 · Reply
simonds
simonds Jun. 24 at 4:23 PM
$PFE Go down faster please
0 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Jun. 24 at 4:18 PM
$PFE - We're an Orange Chip now! Pioneers! I'm so proud, whee!
1 · Reply
STOCKPICKERTRADER
STOCKPICKERTRADER Jun. 24 at 4:15 PM
$PFE picked up some shares
1 · Reply